Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Application of infrapatellar fat pad-derived stem cells after surgical reconstruction of a ruptured cranial cruciate ligament in a dog.

Seo MG., Park S., Han S., Moon CH., Jeong KS., Hong IH.

Case Report / Series on Ligament Injury, Scar, Chronic Inflammation, published in Vet Res Commun (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Vet Res Commun (2026)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
41902883
DOI
10.1007/s11259-026-11175-7

Abstract (original English)

Adipose-derived stem cells (ASCs) have been utilized in regenerative and anti-inflammatory therapies. Among the various sources of ASCs, infrapatellar fat pad-derived adipose stem cells (IFP-ASCs) have been proposed as an alternative source for treating orthopedic diseases in humans; however, their clinical application remains limited. Furthermore, clinical reports on the use of IFP-ASCs are scarce in veterinary medicine. The present report describes the first clinical application of IFP-ASCs in a dog following surgical reconstruction of a ruptured cranial cruciate ligament (CCL). After intra-articular injections of IFP-ASCs adjunctive to surgical stabilization, reductions in inflammatory cytokine levels and improvements in clinical orthopedic scores were observed without any adverse effects. This case suggests that autologous IFP-ASC treatment after surgical CCL reconstruction may be a safe and effective adjunctive treatment for canine joint disorders.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AnimalsDogsAdipose TissueAnterior Cruciate LigamentAnterior Cruciate Ligament InjuriesDog DiseasesRuptureStem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research